• Oncolytics Biotech® to Present Phase 2 Triple-Negative Breast Cancer Trial Update at the 2021 San Antonio Breast Cancer Symposium

    15 days ago - By San Diego Biotechnology

    SAN DIEGO and CALGARY, AB: IRENE study is evaluating pelareorep-anti-PD-1 combination treatment in metastatic TNBC SAN DIEGO and CALGARY, AB, Nov. 19, 2021 /PRNewswire/ - Oncolytics Biotech® Inc. today announced that the Company will present an update on the Phase 2 IRENE trial in a poster...
    Read more ...

     

  • Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo

    15 days ago - By Fierce Biotech

    Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo ntaylor
    Fri, 11/19/2021 - 05:04
    Read more ...